These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 32723206)
21. Perspectives of older people with uncontrolled type 2 diabetes mellitus towards medication adherence: A qualitative study. Upamali S; Rathnayake S PLoS One; 2023; 18(8):e0289834. PubMed ID: 37561681 [TBL] [Abstract][Full Text] [Related]
22. Using the extended self-regulatory model to characterise diabetes medication adherence: a cross-sectional study. Shiyanbola OO; Unni E; Huang YM; Lanier C BMJ Open; 2018 Nov; 8(11):e022803. PubMed ID: 30478112 [TBL] [Abstract][Full Text] [Related]
23. Reasons for non-adherence to cardiometabolic medications, and acceptability of an interactive voice response intervention in patients with hypertension and type 2 diabetes in primary care: a qualitative study. Kassavou A; Sutton S BMJ Open; 2017 Aug; 7(8):e015597. PubMed ID: 28801402 [TBL] [Abstract][Full Text] [Related]
24. Influence of Health Literacy on Medication Adherence Among Elderly Females With Type 2 Diabetes in Pakistan. Hussain N; Said ASA; Khan Z Int Q Community Health Educ; 2020 Oct; 41(1):35-44. PubMed ID: 31886737 [TBL] [Abstract][Full Text] [Related]
25. Building Medication Profiles in the Elderly: a Qualitative Study Based on Medication Information Literacy in a Long-Term Care Facility. Zhou X; Du F; Peng W; Bai L; Peng L; Hou X Clin Interv Aging; 2024; 19():779-793. PubMed ID: 38751855 [TBL] [Abstract][Full Text] [Related]
26. Adherence to Oral Anticancer Therapeutics in the Gynecologic Oncology Population. Watson CH; Fish LJ; Falkovic M; Monuszko K; Lorenzo A; Havrilesky LJ; Secord AA; Davidson BA Obstet Gynecol; 2020 Dec; 136(6):1145-1153. PubMed ID: 33156183 [TBL] [Abstract][Full Text] [Related]
27. Medication adherence in patients with diabetes and dyslipidemia: associated factors and strategies for improvement. Marzec LN; Maddox TM Curr Cardiol Rep; 2013 Nov; 15(11):418. PubMed ID: 24057772 [TBL] [Abstract][Full Text] [Related]
28. Functional health literacy, medication-taking self-efficacy and adherence to antiretroviral therapy. Colbert AM; Sereika SM; Erlen JA J Adv Nurs; 2013 Feb; 69(2):295-304. PubMed ID: 22489684 [TBL] [Abstract][Full Text] [Related]
29. The effects of self-management education tailored to health literacy on medication adherence and blood pressure control among elderly people with primary hypertension: A randomized controlled trial. Delavar F; Pashaeypoor S; Negarandeh R Patient Educ Couns; 2020 Feb; 103(2):336-342. PubMed ID: 31451361 [TBL] [Abstract][Full Text] [Related]
30. Identifying Brief Message Content for Interventions Delivered via Mobile Devices to Improve Medication Adherence in People With Type 2 Diabetes Mellitus: A Rapid Systematic Review. Long H; Bartlett YK; Farmer AJ; French DP J Med Internet Res; 2019 Jan; 21(1):e10421. PubMed ID: 30626562 [TBL] [Abstract][Full Text] [Related]
31. Impact of health literacy on medication adherence in older people with chronic diseases. Lee YM; Yu HY; You MA; Son YJ Collegian; 2017; 24(1):11-8. PubMed ID: 29218957 [TBL] [Abstract][Full Text] [Related]
32. Asthma medication adherence among urban teens: a qualitative analysis of barriers, facilitators and experiences with school-based care. Blaakman SW; Cohen A; Fagnano M; Halterman JS J Asthma; 2014 Jun; 51(5):522-9. PubMed ID: 24494626 [TBL] [Abstract][Full Text] [Related]
33. Patterns and predictors of medication discrepancies in primary care. Coletti DJ; Stephanou H; Mazzola N; Conigliaro J; Gottridge J; Kane JM J Eval Clin Pract; 2015 Oct; 21(5):831-9. PubMed ID: 26032916 [TBL] [Abstract][Full Text] [Related]
34. Facilitating barriers: Contextual factors and self-management of type 2 diabetes in urban settings. Banasiak K; Hux J; Lavergne C; Luk J; Sohal P; Paty B Health Place; 2020 Jan; 61():102267. PubMed ID: 32329732 [TBL] [Abstract][Full Text] [Related]
35. Identifying and Understanding Barriers and Facilitators to Medication Adherence Among Marshallese Adults in Arkansas. McElfish PA; Balli ML; Hudson JS; Long CR; Hudson T; Wilmoth R; Rowland B; Warmack TS; Purvis RS; Schulz T; Riklon S; Holland A; Dickey T J Pharm Technol; 2018 Oct; 34(5):204-215. PubMed ID: 34860999 [No Abstract] [Full Text] [Related]
36. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model. Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515 [TBL] [Abstract][Full Text] [Related]
37. Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review. Tiktin M; Celik S; Berard L Curr Med Res Opin; 2016; 32(2):277-87. PubMed ID: 26565758 [TBL] [Abstract][Full Text] [Related]
38. Assessing barriers to diabetes medication adherence using the Information-Motivation-Behavioral skills model. Nelson LA; Wallston KA; Kripalani S; LeStourgeon LM; Williamson SE; Mayberry LS Diabetes Res Clin Pract; 2018 Aug; 142():374-384. PubMed ID: 29879495 [TBL] [Abstract][Full Text] [Related]
39. The barriers and facilitators people with diabetes from a nonEnglish speaking background experience when managing their medications: a qualitative study. Claydon-Platt K; Manias E; Dunning T J Clin Nurs; 2014 Aug; 23(15-16):2234-46. PubMed ID: 24372586 [TBL] [Abstract][Full Text] [Related]
40. Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives. Onwuchuluba EE; Oyetunde OO; Soremekun RO J Patient Exp; 2021; 8():23743735211034338. PubMed ID: 34368436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]